The Long-Term Cost Effectiveness of Treatments for Benign Prostatic Hyperplasia

被引：0
|
作者：
Rachael L. DiSantostefano
Andrea K. Biddle
John P. Lavelle
机构：
[1] School of Public Health,Department of Health Policy and Administration
[2] University of North Carolina at Chapel Hill,Carolina Program in Healthcare and Aging Research
[3] Institute on Aging,Division of Urology
[4] University of North Carolina,undefined
[5] School of Medicine,undefined
[6] University of North Carolina,undefined
来源：
PharmacoEconomics | 2006年 / 24卷
关键词：
Benign Prostatic Hyperplasia; Lower Urinary Tract Symptom; Urinary Symptom; Watchful Waiting; Utility Weight;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：171 / 191
页数：20
相关论文
共 50 条
  • [31] The Effects of Medical Treatments Used for Benign Prostatic Hyperplasia on Ejaculation
    Kayikci, Ali
    Kacagan, Coskun
    Tekin, Ali
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2015, 14 (04): : 308 - 311
  • [32] Long-term treatment with doxazosin in men with benign prostatic hyperplasia: 10-year follow-up
    Dutkiewicz, Slawomir
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2004, 36 (02) : 169 - 173
  • [33] The International Terazosin Trial: A multicentre study of the long-term efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia
    Debruyne, FMJ
    Witjes, WPJ
    Fitzpatrick, J
    Kirby, R
    Kirk, D
    Prezioso, D
    EUROPEAN UROLOGY, 1996, 30 (03) : 369 - 376
  • [34] Long-term clinical and bioloidc effects of the lipidosterolic extract of Serenoa repens in patients with symptomatic benign prostatic hyperplasia
    Pytel, YA
    Vinarov, A
    Lopatkin, N
    Sivkov, A
    Gorilovsky, L
    Raynaud, JP
    ADVANCES IN THERAPY, 2002, 19 (06) : 297 - 306
  • [35] Cost Comparison of Benign Prostatic Hyperplasia Treatment Options
    Molly E. DeWitt-Foy
    Bradley C. Gill
    James C. Ulchaker
    Current Urology Reports, 2019, 20
  • [36] Long-term treatment of Benign Prostatic Hyperplasia with the combination of alpha blockers and 5-alpha reductase inhibitors
    Ozer, Cevahir
    Tekin, Mehmet Ilteris
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2013, 12 (04): : 263 - 266
  • [37] A systematic review of novel surgical treatments for benign prostatic hyperplasia
    Panayi, Zoe
    Musgrave, Hannah
    Adeyoju, Adebanji
    JOURNAL OF CLINICAL UROLOGY, 2025,
  • [38] Long-term clinical and biologic effects of the lipidosterolic extract ofSerenoa repens in patients with symptomatic benign prostatic hyperplasia
    Y. A. Pytel
    A. Vinarov
    N. Lopatkin
    A. Sivkov
    L. Gorilovsky
    J. P. Raynaud
    Advances in Therapy, 2002, 19 : 297 - 306
  • [39] Long-term treatment with doxazosin in men with benign prostatic hyperplasia: 10-year follow-up
    Sławomir Dutkiewicz
    International Urology and Nephrology, 2004, 36 : 169 - 173
  • [40] Long-Term Risk of Surgery Following First Diagnosis of Benign Prostatic Hyperplasia in Middle-Aged Men
    Rojanasarot, Sirikan
    Cutone, Benjamin
    Bhattacharyya, Samir
    DeRouen, Kyle
    Miller, Larry E.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (01)
12345